Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Squamous Intraepithelial Lesions × Antigens × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Squamous Intraepithelial Lesions 1

Interventions

VGX-3100 3 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2 Restraint, Physical 1 Radiofrequency Ablation 1 Human Papillomavirus DNA Tests 1 GPI0100 1 Electroporation 1 Colposcopy 1 Antigens 1 Adjuvants, Pharmaceutic 1 5-aminolaevulinic acid-n-pentylester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02576561 2017-10-25

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

THEVAX Genetics Vaccine

Phase 2 Unknown

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡